Anastrozole
Back to searchMolecule Structure
Scientific Name
Anastrozole
Description of the Drug
Anastrozole is a competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01217
http://www.drugbank.ca/drugs/DB01217
Brand Name(s)
Anastrozole, Arimidex, Nastrosa
Company Owner(s)
Cipla Ltd, Picket Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Impax Laboratories Inc, Fresenius Kabi Usa Llc, Sun Pharmaceutical Industries Ltd., Accord Healthcare Inc, Ani Pharmaceuticals Inc, Sandoz Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Cytochrome P450 19A1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1978 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL9726 | |
PharmGKB | PA448432 | |
Human Metabolome Database | HMDB0015348 | |
DrugBank | DB01217 | |
PubChem: Thomson Pharma | 14751420 | |
PubChem | 2187 | |
Mcule | MCULE-3029589501 | |
LINCS | LSM-5631 | |
Nikkaji | J592.428F | |
BindingDB | 10015 | |
EPA CompTox Dashboard | DTXSID9022607 | |
DrugCentral | 210 | |
Brenda | 19102 | 219759 |
ChemicalBook | CB3121715 | |
Guide to Pharmacology | 5137 | |
rxnorm | ANASTROZOLE | ARIMIDEX |
PubChem: Drugs of the Future | 12014321 | |
KEGG Ligand | C08159 | |
ChEBI | 2704 | |
ZINC | ZINC000000000941 |